IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Hovione to Buy Irish Pharma Ingredients Site from Pfizer

12:58 PM MST | December 19, 2008 | Alex Scott

Hovione (Loures, Portugal) says it has agreed to buy Pfizer’s multipurpose active pharmaceutical ingredient (API) plant at Loughbeg, Ireland. The deal is scheduled to be completed by early April 2009. Financial terms were not disclosed. Loughbeg: Hovione eyes first site in Ireland. The site, to be renamed Hovione Cork, manufactures intermediates for APIs for Pfizer’s cholesterol-lowering drug Lipitor. Hovione, which has plants in Portugal and China, says it will continue to provide manufacturing services for Pfizer under the deal. Hovione Cork will...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa